291 related articles for article (PubMed ID: 9445385)
1. Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization.
Taube R; Loya S; Avidan O; Perach M; Hizi A
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):579-87. PubMed ID: 9445385
[TBL] [Abstract][Full Text] [Related]
2. DNA synthesis exhibited by the reverse transcriptase of mouse mammary tumor virus: processivity and fidelity of misinsertion and mispair extension.
Taube R; Avidan O; Bakhanashvili M; Hizi A
Eur J Biochem; 1998 Dec; 258(3):1032-9. PubMed ID: 9990322
[TBL] [Abstract][Full Text] [Related]
3. Catalytic features of the recombinant reverse transcriptase of bovine leukemia virus expressed in bacteria.
Perach M; Hizi A
Virology; 1999 Jun; 259(1):176-89. PubMed ID: 10364502
[TBL] [Abstract][Full Text] [Related]
4. The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.
Entin-Meer M; Sevilya Z; Hizi A
Biochem J; 2002 Oct; 367(Pt 2):381-91. PubMed ID: 12097136
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
[TBL] [Abstract][Full Text] [Related]
6. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 2002 Mar; 362(Pt 3):685-92. PubMed ID: 11879196
[TBL] [Abstract][Full Text] [Related]
7. The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus.
Rubinek T; Loya S; Shaharabany M; Hughes SH; Clark PK; Hizi A
Eur J Biochem; 1994 Feb; 219(3):977-83. PubMed ID: 7509281
[TBL] [Abstract][Full Text] [Related]
8. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Hizi A; Tal R; Hughes SH
Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
[TBL] [Abstract][Full Text] [Related]
12. Soluble Rous sarcoma virus reverse transcriptases alpha, alphabeta, and beta purified from insect cells are processive DNA polymerases that lack an RNase H 3' --> 5' directed processing activity.
Werner S; Wöhrl BM
J Biol Chem; 1999 Sep; 274(37):26329-36. PubMed ID: 10473589
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of a recombinant novel reverse transcriptase of a porcine endogenous retrovirus.
Avidan O; Loya S; Tönjes RR; Sevilya Z; Hizi A
Virology; 2003 Mar; 307(2):341-57. PubMed ID: 12667803
[TBL] [Abstract][Full Text] [Related]
14. An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase.
Evans DB; Fan N; Swaney SM; Tarpley WG; Sharma SK
J Biol Chem; 1994 Aug; 269(34):21741-7. PubMed ID: 7520442
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of the reverse transcriptase enzyme from type 1 human immunodeficiency virus using different baculoviral vector systems.
Pekrun K; Petry H; Jentsch KD; Moosmayer D; Hunsmann G; Lüke W
Eur J Biochem; 1995 Dec; 234(3):811-8. PubMed ID: 8575439
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.
Chattopadhyay D; Evans DB; Deibel MR; Vosters AF; Eckenrode FM; Einspahr HM; Hui JO; Tomasselli AG; Zurcher-Neely HA; Heinrikson RL
J Biol Chem; 1992 Jul; 267(20):14227-32. PubMed ID: 1378437
[TBL] [Abstract][Full Text] [Related]
17. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
Wilhelm M; Boutabout M; Wilhelm FX
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
[TBL] [Abstract][Full Text] [Related]
18. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
Loya S; Tal R; Hughes SH; Hizi A
J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
[TBL] [Abstract][Full Text] [Related]
19. Recombinant reverse transcriptase of Rous sarcoma virus: characterization of DNA polymerase and RNAase H activities.
Chernov AP; Mel'nikov AA; Fodor II
Biomed Sci; 1991; 2(1):49-53. PubMed ID: 1717011
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
